The South African Hypertension Guideline 2006 is evidence-based and not cost-effective--a rebuttal.
Rayner
B L
BL
Seedat
Y K
YK
Milne
J
J
Pinkney-Atkinson
V
V
Veriava
Y
Y
D000959:Antihypertensive Agents / Q000191:economics* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology; D003362:Cost-Benefit Analysis; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D013019:South Africa
D000959:Antihypertensive Agents